Copyright
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Aug 6, 2023; 11(22): 5273-5287
Published online Aug 6, 2023. doi: 10.12998/wjcc.v11.i22.5273
Published online Aug 6, 2023. doi: 10.12998/wjcc.v11.i22.5273
Meta-analysis of outcomes from drug-eluting stent implantation in infrapopliteal arteries
Ming-Xuan Li, Hai-Xia Tu, Meng-Chen Yin, Department of Vascular Surgery, Beijing Fengtai You'anmen Hospital, Beijing 100069, China
Author contributions: Li MX designed the study; Li MX and Tu HX performed the article search, data extraction, and evidence quality assessment; Li MX and Yin MC performed the risk of bias assessment of the studies; Li MX performed the data analyses and manuscript writing; Tu HX reviewed the article independently and made minor revisions after consultation with Li MX; All the authors read and gave final approval of the version to be submitted; Tu HX is the guarantor of the review.
Conflict-of-interest statement: The authors declare that they have no conflicts of interest to report.
PRISMA 2009 Checklist statement: The authors have read the PRISMA 2009 Checklist, and the manuscript was prepared and revised according to the PRISMA 2009 Checklist.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Hai-Xia Tu, MM, Chief Physician, Department of Vascular Surgery, Beijing Fengtai You'anmen Hospital, No. 199 You'anmenwai Street, Beijing 100069, China. haixia_tu2023@163.com
Received: May 5, 2023
Peer-review started: May 5, 2023
First decision: July 3, 2023
Revised: July 7, 2023
Accepted: July 17, 2023
Article in press: July 17, 2023
Published online: August 6, 2023
Processing time: 90 Days and 3.4 Hours
Peer-review started: May 5, 2023
First decision: July 3, 2023
Revised: July 7, 2023
Accepted: July 17, 2023
Article in press: July 17, 2023
Published online: August 6, 2023
Processing time: 90 Days and 3.4 Hours
Core Tip
Core Tip: The utility of drug-eluting stents (DESs) for infrapopliteal artery diseases was explored using traditional percutaneous transluminal angioplasty with or without bare stent implantation as control. The results suggest that the DES is superior on multiple outcomes. The hazard ratio, which is most appropriate for various outcomes categorized as time-to-event data by type, was adopted as the outcome measure, rather than the relative risk or the odds ratio.